Opioid Use Disorder Treatment Integrated with Primary Care-MOUD 2-hr Training Slide Set

MOUD 2-hr Training Slide Set

Pdf Summary

This document provides an overview of opioid use disorder treatment integrated with primary care. The author declares no conflicts of interest. The learning objectives include reviewing the integration of substance use disorder (SUD) treatment and primary care, understanding the medications for opioid use disorder (OUD), describing the process of buprenorphine initiation and maintenance, discussing the importance of harm reduction, and reviewing the steps for completing the online waiver application.<br /><br />The document highlights the reasons why everyone should have an "x waiver" for prescribing buprenorphine, including caring for patients in opioid withdrawal, covering for other providers who prescribe buprenorphine, and integrated care for patients on buprenorphine.<br /><br />The integration of SUD treatment and primary care is recommended by the Institute of Medicine and offers improved care and quality of life. Providers should expect their patients with addiction to have knowledge about addiction, a duty to treat, focus on overall health, engagement in care, and treatment for the full scope of illness.<br /><br />The document provides information on opioids and opiates, the regulation of narcotics in the United States, the diagnostic criteria for opioid use disorder according to the DSM-5, and the management of OUD, which includes treatment and prevention strategies.<br /><br />The different options for OUD treatment are discussed, including medication-based treatment (Methadone, Buprenorphine, and Naltrexone), simple detoxification, counseling or peer support without medication, and referral to residential treatment.<br /><br />The document emphasizes the importance of interventions and education, the effectiveness of treatment for opiate addiction, and the goals of pharmacotherapy, which include preventing withdrawal symptoms, reducing drug use and its complications, and improving morbidity and mortality.<br /><br />In terms of specific medications, the document discusses the features, initiation, and safety of Methadone, Naltrexone, and Buprenorphine. It also provides guidance on buprenorphine initiation and maintenance, monitoring efficacy, and avoiding precipitated withdrawal.<br /><br />The document includes patient vignettes, highlighting the benefits of integrating buprenorphine treatment in primary care for patients with chronic pain, joint infections, and substance use disorders. Harm reduction strategies such as needle exchange programs and naloxone distribution are also discussed.<br /><br />Lastly, the document touches upon the importance of appropriate language when discussing addiction and provides resources for assistance and training in addiction treatment. It also explains the process of completing the online waiver application for prescribing buprenorphine and introduces Maryland's Medication Assisted Clinical Support (MACS) program, which offers support and resources for prescribers and healthcare teams treating substance use disorders and chronic pain management.

Keywords

opioid use disorder treatment

primary care integration

substance use disorder treatment

medications for opioid use disorder

buprenorphine initiation and maintenance

harm reduction

online waiver application

prescribing buprenorphine

SUD treatment integration

Maryland's Medication Assisted Clinical Support program